Customized Stability Studies

As part of a comprehensive CMC program offering, RCI offers ICH-compliant stability studies for both drug substance and drug product candidates.  Further, we have extensive experience developing R&D-based (non-ICH compliant) stability studies for important intermediates in the life science space or final products with non-life science applications (i.e. coatings, stabilizers, dyes).  Please contact us to discuss the type of stability study that is optimal for your new product!

Christopher Kulp
Chief Commercial Officer
Richman Chemical Inc.
P:  215-628-4632, x-13
F:  215-628-4262


Click here to see all of Richman Chemical's newsletters.